Chemical Properties:
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureRuifu Chemical Supply Omeprazole Intermediates With High Purity Omeprazole CAS 73590-58-6 Omeprazole Hydroxy Compound CAS 86604-78-6 Omeprazole Chloride Compound CAS 86604-75-3 Omeprazole Sulfide CAS 73590-85-9 2-Mercapto-5-Methoxybenzimidazole CAS 37052-78-1 2-Cyano-3-Methylpyridine CAS 20970-75-6 2,3,5-Trimethylpyridine CAS 695-98-7| Item | Specifications |
| Appearance | White or Off-White Crystalline Powder |
| Identification | IR Conforms to Standard |
| Purity / Analysis Method | >99.5% (HPLC) |
| Melting Point | 60.0~63.0℃ |
| Water (K.F) | <0.50% |
| Single Impurity | <0.30% |
| Total Impurities | <0.50% |
| Infrared Spectrum | Conforms to Structure |
| Test Standard | Enterprise Standard |
| Usage | Intermediate of Omeprazole (CAS: 73590-58-6) |
Description:
Specifications:
Package & Storage:
| Chemical Name | 4-Methoxy-3,5-Dimethyl-2-Pyridinemethanol |
| Synonyms | Omeprazole Hydroxy Compound; 2-Hydroxymethyl-4-Methoxy-3,5-Dimethylpyridine; 3,5-Dimethyl-4-Methoxy-2-Pyridinemethanol |
| CAS Number | 86604-78-6 |
| CAT Number | RF-PI1911 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C9H13NO2 |
| Molecular Weight | 167.21 |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
4-Methoxy-3,5-Dimethyl-2-Pyridinemethanol, also known as Omeprazole Hydroxy Compound, (CAS: 86604-78-6) is an intermediate of Omeprazole (CAS: 73590-58-6). Omeprazole is mainly used for duodenal ulcer and Zollinger-Ehrle syndrome. It can also be used for gastric ulcer and reflux esophagitis; intravenous injection can be used for the treatment of acute bleeding in peptic ulcer. Combine with amoxicillin and clindamycin or metronidazole and clarithromycin to kill Helicobacter pylori. 1. Peptic ulcer bleeding and anastomotic ulcer bleeding; 2. Acute gastric mucosal injury complicated by stress and acute gastric mucosal injury caused by nonsteroidal anti-inflammatory drugs; 3. Prevention of severe diseases (such as cerebral hemorrhage, severe trauma, etc.) stress state and upper gastrointestinal bleeding caused by gastric surgery; 4. As an alternative when oral therapy is not appropriate for duodenal ulcer, gastric ulcer, reflux esophagitis, and zollinger-ellison syndrome; 5. Applied in pharmaceutical filed, drugs inhibiting gastric acid secretion.
